Tasimelteon
Overview
Tasimelteon is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2103822).
API suppliers (3)
Suppliers of Tasimelteon evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
2 of 3 hold a GMP certificate on record in the EU or UK registers
- Apotex Inc.Canada1 active DMF
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- Zhejiang Ausun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (5 approved US products), the latest listed US patent on Tasimelteon expires 21 Feb 2041 and exclusivity 1 Dec 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl]propanamide
- Canonical SMILES
- CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2
- InChIKey
- PTOIAAWZLUQTIO-GXFFZTMASA-N
Do you supply Tasimelteon? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.